Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05503524|
Recruitment Status : Not yet recruiting
First Posted : August 16, 2022
Last Update Posted : August 16, 2022
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Multiple Sclerosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Multiple Sclerosis patients.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Extensive Clinical Trial Experiences of Multiple Sclerosis Patients To Determine Trial Attributes Affecting Completion Rates For Specific Demographic Groups|
|Estimated Study Start Date :||September 10, 2022|
|Estimated Primary Completion Date :||September 10, 2023|
|Estimated Study Completion Date :||September 10, 2024|
- Rate of patients who decide to enroll in a Multiple Sclerosis Clinical Trial [ Time Frame: 3 months ]
- Number of patients who remain in Multiple Sclerosis clinical trial until completion [ Time Frame: 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05503524
|Contact: Michael B Gillfirstname.lastname@example.org|
|Study Director:||Michael B Gill||Power Life Sciences Inc.|